Given that our study cohort was solely IDH-mutant, this provided a unique opportunity to investigate this phenomenon via a metabolomics approach, since correlations of 2-HG levels with other associated metabolites might provide additional insight on the cancer-promoting activity of 2-HG. The gene discussed is IDH1; the disease is cancer.